Abstract Details

Title Trends in Outcomes and Hospitalization Charges among Adult Patients with Guillain- Barrie Syndrome, Treated with Plasmapheresis in the United States (1992-2009)

Topic Critical Care/Emergency Neurology/Trauma

Presentation(s) P01 - (-)

Poster/Presentation
Number 032

Objective

Background New treatments have been introduced in the last two decades for adult patients on plasmapheresis, suffering from Guillain- Barrie syndrome, which are expected to improve the associated in-hospital outcomes.

Design/Methods We determined the rates of occurrence, in-hospital outcomes, and mean hospital charges for adult patients on plasmapheresis, hospitalized with Guillain- Barrie syndrome, from 1992 to 2009 using Nationwide Inpatient Survey (NIS).

Results The total number (N=1074) of admission varied between 27 patients in 2008 to 87 patients in 1998. The proportion of males was significantly different (P<0.01) from females during the study period and varied between 40.5% in 2006 and 75.3% in 1999. The average age (in years±SD) was not significantly different during the study time-period and varied between 42.02±12.46 in 1994 and 47.73±10.44 in 2006 (P>0.3). The length of hospitalization was not significantly different during the study period (P>0.06). The maximum mean hospital stay (in days ±standard deviation) was 14.75±9.7 in 1992, and the minimum was 8.91±5.1 in 2005. There was significant increase (P<0.0001) in mean hospital charges from 1992 to 2009, even after correction for inflation. The highest average hospitalization charges were $119602.63±84941.3 in 2008, and lowest were $28478.3±19606.5 in 1993. In-hospital mortality was not significantly different during the study period (P > 0.5).

Conclusions Despite a continuous increase of mean hospitalization charges, there was no continuous reduction of length of hospitalization for adult patients treated with plasmapheresis, suffering from Guillain-Barrie syndrome, hospitalized from 1992 to 2009 in United States.

Authors/Disclosures
PRESENTER	No disclosure on file
Francois H. Jacques, MD (Clinique Neuro-Outaouais)	No disclosure on file
	No disclosure on file
Rania A. Elenein, MD (Jefferson Health NJ)	Dr. Elenein has nothing to disclose.
Zaid Al-Qudah, MD (Associate Specialist Inc.)	No disclosure on file
Nizar Souayah, MD, FAAN (NJMS)	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��